General Information of Drug Therapeutic Target (DTT) (ID: TT7Y3EJ)

DTT Name D-amino acid oxidase (DAO)
Synonyms Daminoacid oxidase; DAMOX; DAAO
Gene Name DAO
DTT Type
Clinical trial target
[1]
BioChemical Class
CH-NH(2) donor oxidoreductase
UniProt ID
OXDA_HUMAN
TTD ID
T33124
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
EC 1.4.3.3
Sequence
MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPN
NPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPR
ELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVN
CTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGG
IFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGP
SNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL
Function
Regulates the level of the neuromodulator D-serine in the brain. Has high activity towards D-DOPA and contributes to dopamine synthesis. Could act as a detoxifying agent which removes D-amino acids accumulated during aging. Acts on a variety of D-amino acids with a preference for those having small hydrophobic side chains followed by those bearing polar, aromatic, and basic groups. Does not act on acidic amino acids.
KEGG Pathway
Glycine, serine and threonine metabolism (hsa00260 )
Arginine and proline metabolism (hsa00330 )
D-Arginine and D-ornithine metabolism (hsa00472 )
Metabolic pathways (hsa01100 )
Biosynthesis of antibiotics (hsa01130 )
Peroxisome (hsa04146 )
Reactome Pathway
Peroxisomal protein import (R-HSA-9033241 )
Glyoxylate metabolism and glycine degradation (R-HSA-389661 )
BioCyc Pathway
MetaCyc:HS03351-MON

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
TAK-831 DMWPSJR Friedreich's ataxia 8A03.10 Phase 2 [1]
------------------------------------------------------------------------------------
1 Discontinued Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
SEP-227900 DMXRU72 Cognitive impairment 6D71 Terminated [2]
------------------------------------------------------------------------------------

The Drug-Metabolizing Enzyme (DME) Role of This DTT

DTT DME Name D-amino-acid oxidase (DAO) DME Info
Gene Name DAO
1 Approved Drug(s) Metabolized by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
D-Serine DM3YH4I N. A. N. A. Phase 4 [3]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors. Open Med Chem J. 2010; 4: 3-9.
3 Focus on the role of D-serine and D-amino acid oxidase in amyotrophic lateral sclerosis/motor neuron disease (ALS). Front Mol Biosci. 2018 Feb 13;5:8.